SCPX
Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q3 | -0.02 | $229,842 | -$2.92T |
| 2025 Q2 | -0.09 | $2M | -$6.83T |
| 2025 Q1 | -1.16 | $212,264 | -$3M |
| 2024 Q4 | -1.85 | $1M | -$5M |
| 2024 Q3 | -1.43 | $922,365 | -$9M |
| 2024 Q2 | -26.98 | $759,944 | -$7M |
| 2024 Q1 | -31.35 | $4M | -$5M |
| 2023 Q4 | -41.25 | $5M | -$1M |